What Researchers Did
Researchers prospectively evaluated thiol/disulfide homeostasis parameters in 66 patients with carbon monoxide poisoning treated with either hyperbaric oxygen therapy (HBOT) or normobaric oxygen therapy (NBOT), comparing them to 67 healthy individuals.
What They Found
Before normobaric oxygen therapy (NBOT), native thiol and total thiol levels differed significantly between the 66 carbon monoxide poisoning patients and 67 healthy controls (p < 0.006 for both). Significant differences were also observed in pre- and post-NBOT levels of native thiol and total thiol (p < 0.002, p < 0.003). However, the study found no significant difference in thiol/disulfide parameters when comparing hyperbaric oxygen therapy (HBOT) and NBOT patients.
What This Means for Canadian Patients
For Canadian patients with carbon monoxide poisoning, this study suggests that both normobaric and hyperbaric oxygen therapies may have similar effects on certain oxidative stress markers. This finding could potentially inform treatment decisions, indicating that the choice between these two oxygen therapies might not significantly alter these specific antioxidant levels.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A limitation of this study is the significant imbalance in patient numbers between the hyperbaric oxygen therapy group (8 patients) and the normobaric oxygen therapy group (58 patients).